Dr. Dubois to Lead Discussions on Rapid Learning Health Care Systems and Need for New Evidence @ AcademyHealth’s EDM Forum & Annual Research Meeting
With more physicians utilizing electronic health records (EHRs), the United States’ evidence base is rapidly growing. EHRs and their related data infrastructure will make it possible to collect and analyze real-world data, put the findings into practice and gauge the impact. However, there are still questions remaining as to how exactly this learning health care system will unfold.
With more physicians utilizing electronic health records (EHRs), the United States’ evidence base is rapidly growing. EHRs and their related data infrastructure will make it possible to collect and analyze real-world data, put the findings into practice and gauge the impact. However, there are still questions remaining as to how exactly this learning health care system will unfold. NPC Chief Science Officer Robert Dubois, MD, PhD, will participate in two discussions this weekend exploring the learning health care system and the type of evidence that key stakeholders need.
Dr. Dubois will present at the 4th Annual EDM Forum Stakeholder Symposium, “Evidence, Data, & Methods to Build Learning Health Systems of the Future.” He will join Martin Zagari, MD, VP, global health economics, Amgen, and Paul Wallace, MD, chief medical officer, Optum Labs, in a surfside chat, "Evidence into Action: Perspectives from Industry and Payers," on Saturday, June 7, at 11:45 am PT. The symposium will be held at the Hilton San Diego Bayfront.
The next day at AcademyHealth’s Annual Research Meeting, Dr. Dubois will chair a methods workshop, "Real-World Evidence: When and Why Is it Fit for Purpose?" at San Diego’s Convention Center at 9 am PT.
Panelists will discuss what type of evidence key stakeholders, such as payers and providers, need to aid in their decision-making.
This session will present and consider a framework for determining when new evidence, including real-world evidence from observational or pragmatic studies, may provide sufficient information to change decision-making. The speakers include:
- Jeff White, PharmD, MS, director, drug evaluation and clinical analytics, WellPoint
- Steven Pearson, MD, MSc, FRCP, founder & president, Institute for Clinical and Economic Review
- Lisa Simpson, MB, BCh, MPH, FAAP, president & CEO, AcademyHealth
In addition, NPC will have multiple poster presentations on topics such as comparative effectiveness research and its impact on health care decision-making; how to reduce health care costs related to the small percentage of patients who disproportionately make up a large percentage of overall health care costs (5% of patients spend 50% of health care dollars); and the value of specialty biopharmaceuticals.
Be sure to stop by NPC’s booth (#301) and check out our latest policy research and publications.